Allograft: Clinical Trials

3 trials for Allograft, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 unknown. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 1, Recruiting 1, Unknown 1

Follow Allograft: new trials by email Literature Review of Allograft trials Research Report on Allograft

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Fascia Lata Allograft and Platelet Rich Fibrin on the Periodontal Phenotype Around Dental Implant
Fascia lata membrane, Platlet Rich fibrin membrane, subepithelial connective tissue graft - Allograft
Phase 4UnknownKafrelsheikh University242024-02-012024-01-23
Study to Compare the Outcome of Receiving Continued Immunosuppression Versus Stopping Immunosuppression at 6 Months to Safely Prevent Human Leukocyte Antigen (HLA) Sensitization in Patients With Late Renal Graft Failure
Continue low dose calcineurin inhibitor (CNI), Calcineurin inhibitor withdrawal at 6 months - Renal Failure , Chronic, Graft Failure
Phase 4RecruitingHospital Universitari Vall d'Hebron Research Institute2022024-01-222024-11-06
PK Assessment of Tacrolimus Exposure Before and After a Switch From Twice Daily Immediate-release (Prograf®) to Once-daily Prolonged Release Tacrolimus (Envarsus®)
switched from Prograf® to Envarsus® - Allograft
Phase 4CompletedUniversity Hospital, Limoges1342016-10-012025-11-21

Narrower conditions

Renal Insufficiency (1)  ·  Renal Insufficiency, Chronic (1)

Broader conditions

Chronic Disease (1)  ·  Disease Attributes (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Urogenital Diseases (1)  ·  Urologic Diseases (1)

Interventions

Calcineurin Inhibitors (1)

Sponsors

Hospital Universitari Vall d'Hebron Research Institute (1)  ·  Kafrelsheikh University (1)  ·  University Hospital, Limoges (1)

Countries

France (1)  ·  Spain (1)

Results publications

PMID 37588007

NIH funding

2023 (1)